The opportunity
As the Director of Business Development you will be responsible for supporting the generics and biosimilars businesses of Teva globally, with focus on Teva's US business, through pursuing and execution of generic and biosimilar pharmaceutical products’ licensing-in and co-development projects, to complement Teva's broad product portfolio, and other business development activities. Your role will also include pursuing and executing projects aimed at optimizing Teva’s portfolio, also through product acquisitions, divestments, and co-marketing. The position includes identifying and evaluating products' licensing and other business development opportunities, identifying and building relationships with potentially strategic partners for implementing business development projects, leading due diligence and negotiations procedures and coordinating such activities with relevant functions within Teva to deal finalization. You will contribute to Teva’s growth, primarily in the US market, through expanding Teva’s network of potential business development partners and increasing the number of opportunities brought to assessment of senior management, by initiating discussions with companies you have engaged with in the past and strengthening the relationships with companies Teva currently works with.
This position will be based hybrid in the Parsippany, NJ office 3 days a week.
Will consider visa sponsorhip for the right candidate.How you’ll spend your day
Apply pharmacy knowledge and training to manage, coordinate, and execute licensing and business development agreements involving generic and biosimilar pharmaceuticals, with a focus on evaluating clinical relevance, therapeutic classification, and patient treatment pathways.
Lead due diligence activities requiring pharmacist-level expertise, including review of drug monographs, pharmacokinetic profiles, bioequivalence data, safety information, and compliance with FDA and international regulatory frameworks (e.g., ANDA, EMA).
Assess and advise on drug product opportunities by analyzing formulation strategies, therapeutic use, dosage forms, and substitution potential, ensuring that new products align with standards for clinical efficacy and pharmacy practice.
Contribute to scientific evaluation and commercial strategy using knowledge of drug interactions, adverse effects, labeling standards, and quality assurance—core areas of pharmacist expertise critical to business development decisions.
Serve as pharmacy subject matter expert in business development negotiations and internal strategic meetings, guiding stakeholders on issues of therapeutic equivalence, pharmacovigilance requirements, and patient-centered product positioning.
Collaborate cross-functionally with Teva’s regulatory, R&D, medical, and commercial teams to integrate pharmacist-level input on drug safety, efficacy, labeling, and lifecycle planning for new and existing products.
Provide pharmacist-based insight in evaluating market access strategies and formulary inclusion potential, based on clinical guidelines, standard of care considerations, and cost-effectiveness from a patient and provider perspective.
Support the expansion of Teva’s U.S. generics portfolio by identifying product candidates and development partnerships that meet unmet therapeutic needs, reduce treatment cost burden, and comply with clinical pharmacy practice expectations.
The offered role of Senior Director Business Development – Generics, requires the application of a professional degree in Pharmacy, or a related field, to assist Teva in the assessment, evaluation, and strategic development of pharmaceutical products. The position involves use of clinical pharmacology knowledge, including therapeutic classification, dosage forms, bioequivalence, and regulatory pathways (e.g., ANDA) to support business development decisions involving generic and biosimilar drugs. The candidate’s expertise in drug interactions, labeling, safety, and therapeutic efficacy is essential to evaluating new products and partnerships. As such, this role draws directly on core competencies gained through pharmacy education and practice.
